Extract from Previous Activities
01/2025 – 05/2025 Pharmaceutical Company, Austria
Interim Brand Lead Neurology
Developed and implemented product strategies for multiple sclerosis (MS) and rare disease (spinal muscular atrophy, SMA). Designed and executed strategic omnichannel activities. Prepared the semi-annual company conference and led workshops for the MS sales team, with end-to-end responsibility for planning, execution, and monitoring of projects and campaigns.
2021 – 2022Pharmaceutical Company, Austria
Senior Brand Manager Immuno-Oncology | Melanoma & Pan-Tumor
Developed a five-year plan and local brand plans. Designed and executed an omni-channel corporate brand campaign and a hybrid event “10 Years of Immuno-Oncology with BMS,” featuring top international KOLs from the USA, Italy, the UK, and Austria. Initiated preparations for a new product launch and contributed to a project on digitalizing processes in Marketing & Sales. Led pan-tumor portfolio activities.
Delivered double-digit revenue growth in the melanoma franchise through strategic initiatives and digital activities
The omni-channel corporate brand campaign, featuring international and Austrian KOLs, increased brand loyalty and brand awareness among early-career hospital physicians
2018 – 2020 Pharmaceutical Company, Austria
Sr. Brand & Portfolio Manager Cardiovascular Critical Care | Germany & Austria
Led project teams comprising country managers and sales & marketing managers across six countries. Developed and implemented marketing and product launch strategies for Italy and Poland, as well as the relaunch strategy for Germany in collaboration with specialized clinics. Managed market access activities and portfolio management in Germany. Designed and delivered a hybrid training program for multiple customer segments across different settings, as well as for marketing and sales staff.
Successful product launches in Germany, Italy, and Poland
Effective training concept tailored to diverse customer groups and complex hospital environments
2019 – 2020 Pharmaceutical Company, Austria
International Marketing Manager Cardiovascular Critical Care | South and East Europe (CEE, IT & GR)
Led project teams comprising country managers and sales & marketing managers across six countries. Developed and implemented marketing and product launch strategies for Italy and Poland, as well as the relaunch strategy for Germany in collaboration with specialized clinics. Managed market access activities and portfolio management in Germany. Designed and delivered a hybrid training program for multiple customer segments across different settings, as well as for marketing and sales staff.
Successful product launches in Germany, Italy, and Poland
Effective training concept tailored to diverse customer groups and complex hospital environments
2018 – 2019 Pharmaceutical Company, Austria
International Brand Manager Cardiovascular Critical Care | Europe & Middle East
Developed a comprehensive marketing and product launch strategy for 20 countries across Europe and the Middle East, with a primary focus on the German market. Led a corporate branding project to refine brand identity and key messages. Planned and executed scientific symposia and educational events, and optimized processes for cross-functional collaboration.
Delivered an end-to-end launch strategy with clear brand/product positioning and key messages, digital marketing activities, and an omnichannel campaign (including materials) for 20 countries
Planned and delivered an international launch kick-off event that catalyzed market entry and brand awareness; identified and established new international key opinion leaders
2016 – 2018Pharmaceutical Company, Austria
Brand Manager Pulmonology | Rare Disease – Idiopathic Pulmonary Fibrosis (IPF)
Led cross-functional brand team within product/ brand promotion, as well as a cross-functional brand team including the COPD & Asthma brand Team to foster awareness among pulmonologists & GPs, through differential diagnosis. Conceptualized and delivered an interdisciplinary awareness project focused on earlier diagnosis of IPF, driving collaboration across medical specialties and increasing understanding among healthcare professionals: hospital and office-based pulmonologists and cardiologists, GPs, and radiologists. Facilitated expert meetings to gather insights and feedback from experts, informing strategic decisions and optimising brand positioning.
Heightened market visibility and enhanced brand reputation by leading brand team to drive product promotion
Enabled earlier diagnosis of Idiopathic Pulmonary Fibrosis (IPF) by implementing unique interdisciplinary scientific platform involving hospital-based specialists, office-based practitioners, and GPs
04/2015 – 11/2015 Pharmaceutical Company, Austria
Brand Manager Oncology | Metastatic Colorectal Cancer (mCRC) and Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Conceived and executed a medical-marketing campaign, including media activities featuring insights from KOLs at the ASCO Congress, and
Initiated collaboration with a top KOL and launched a personalized medicine project focused on oncology biomarkers
Planned the strategy for an advisory board with top Austrian KOLs in collaboration with Medical and Sales
2014 – 2015 Pharmaceutical Company, Austria
Brand Manager Immunology | Dermatology & Rheumatology
Developed the go-to-market strategy and led pre-launch activities for a first-in-class monoclonal antibody for the treatment of psoriasis (Cosentyx). Coordinated Market Access activities with a focus on rare rheumatic diseases to facilitate access to innovative therapies and improve patient outcomes.
Directed preparation of the launch plan and developed business cases
Performed disease awareness & disease management activities, as well as market access activities for the treatment in collaboration with KOLs
2011 – 2014Pharmaceutical Company, Austria
Franchise Manager Autoimmunity | Germany, Austria, Switzerland
Led strategy development and created marketing plans for autoimmunity across the DACH region, delivering successful product launches including the first fully automated calprotectin test and a series of tests for connective tissue diseases. Managed projects and disease-awareness initiatives to support earlier diagnosis of autoimmune diseases, including developing a guide for general practitioners.
Successfully introduced the calprotectin diagnostic in Austria, Germany, and Switzerland, leading to broad market penetration
Developed a DACH KOL platform that increased opinion-leader engagement and helped establish the test as a new standard